scispace - formally typeset
P

Petko Alov

Researcher at Bulgarian Academy of Sciences

Publications -  42
Citations -  408

Petko Alov is an academic researcher from Bulgarian Academy of Sciences. The author has contributed to research in topics: Virtual screening & In silico. The author has an hindex of 10, co-authored 35 publications receiving 299 citations.

Papers
More filters
Journal ArticleDOI

Computational Studies of Free Radical-Scavenging Properties of Phenolic Compounds.

TL;DR: This review aims at presenting the state of the art in quantum chemical and QSAR studies of phenolic antioxidants and at analysing the trends observed in the field in the last decade.
Journal ArticleDOI

Quantitative structure-skin permeability relationships.

TL;DR: This paper reviews in silico models currently available for the prediction of skin permeability and a comprehensive discussion on the developed methods is presented, focusing on quantitative structure-permeability relationships.
Journal ArticleDOI

Molecular Modelling Study of the PPARγ Receptor in Relation to the Mode of Action/Adverse Outcome Pathway Framework for Liver Steatosis

TL;DR: Molecular modelling based on PPARγ complexes with full agonists extracted from the Protein Data Bank yielded results that could facilitate the development of preliminary filtering rules for the effective virtual ligand screening of compounds with PParγ full agonistic activity.
Journal ArticleDOI

Modes-of-Action Related to Repeated Dose Toxicity: Tissue-Specific Biological Roles of PPAR γ Ligand-Dependent Dysregulation in Nonalcoholic Fatty Liver Disease.

TL;DR: The aim of this work was to analyze and systematize the numerous scientific data about the steatogenic role of PPARγ and identify the possible events at different levels of biological organization starting from the MIE to the organ response and the connections between them.
Journal ArticleDOI

The application of molecular modelling in the safety assessment of chemicals: A case study on ligand-dependent PPARγ dysregulation

TL;DR: A proof of concept demonstrating that molecular modelling methodologies can be employed as a part of an integrated strategy to support toxicity prediction consistent with the mode of action/adverse outcome pathway (MoA/AOP) framework is provided.